On the first day of trading, HIGHTIDE-B made its debut and opened at a high of 3.65% in the morning session.
I'm PortAI, I can summarize articles.
HIGHTIDE-B made its debut on the market with an initial listing price of HKD 11.5 per share, issuing 24.194 million shares and raising approximately HKD 194.1 million. On the first day of trading, the stock opened 3.65% higher at HKD 11.92, with a turnover of HKD 25.9612 million. HIGHTIDE-B focuses on the discovery, development, and commercialization of treatments for metabolic and digestive system diseases. Its core product, HTD1801, has demonstrated good safety and efficacy in multiple clinical trials and is expected to become a "one treatment for multiple diseases" product.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments